PVH
MNTA

Psagot Value Holdings’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Psagot Value Holdings’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-12,240
Closed -$147K – 379
2014
Q4 		$147K Buy
12,240
+5,040
+70% +$57.6K 0.01% 269
2014
Q3 		$82K Hold
7,200
– – ﹤0.01% 275
2014
Q2 		$87K Buy
+7,200
New +$85K ﹤0.01% 283

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Psagot Value Holdings's MNTA Position: Q1 2015 in Review

Psagot Value Holdings sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2015, closing a stake of 12,240 shares — an estimated $147K sold.

Psagot Value Holdings first reported a position in MNTA in Q2 2014 and held it in 3 quarters. The position peaked at $147K in Q4 2014. 143 funds tracked by Wall St. Rank hold MNTA as of Q1 2015.

  • Psagot Value Holdings reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • Psagot Value Holdings sold 12,240 Momenta Pharmaceuticals, Inc. shares in Q1 2015, an estimated $147K.
  • Psagot Value Holdings first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2014 and held it in 3 quarters.
  • Psagot Value Holdings's Momenta Pharmaceuticals, Inc. position peaked at $147K in Q4 2014.
  • 143 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2015.

Based on Psagot Value Holdings's 13F filing for Q1 2015, filed 6 May 2015.